DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Cummings J, Isaacson S, Mills R. , et al.
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.
Lancet 2014;
383 (9916): 533-540
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.